Skip to main content
Equibles
CTRE logo

CTRE · CareTrust REIT, Inc. · Metrics

Track CTRE — free

Use CTRE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CTRE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$35.83 -0.63 (-1.71%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$8.61B
Shares
236.29M
Volume · Oct 21 1.27M Avg daily vol (3M) 2.31M

CTRE metrics

87 of 126 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$36.45
Market cap
$8.61B

Price action

20 metrics
Price change (1W)
-0.3%
Price change (30D)
-3.3%
Price change (3M)
-16.0%
Price change (6M)
-5.0%
Price change (YTD)
+0.8%
Price change (1Y)
+3.6%
Trailing year
Price change (5Y)
+69.8%
52-week high
$43.40
52-week low
$33.99
Change from 52-week high
-16.0%
Change from 52-week low
+7.2%
Annualized volatility
25.0%
Annualized volatility (3M)
19.4%
Beta
0.0
RSI (14D)
44.0
Price vs SMA 50
-4.1%
Price vs SMA 200
-6.6%
Avg volume (3M)
2.31M
Relative volume
0.7
Average dollar volume
$89.29M

Company

3 metrics
Sector
Real Estate
Industry
REIT - Healthcare Facilities
Shares outstanding
236.29M

Valuation

14 metrics
P / FFO
23.2×
Company-stated · TTM · reciprocal yield 4.3%
P / AFFO
—
P / E (TTM)
22.6
Trailing earnings · reciprocal yield 4.4%
PEG ratio
2.6
EV / revenue
17.1×
reciprocal yield 5.8%
EV / EBITDA
—
EV / EBIT
—
P / sales
15.1×
reciprocal yield 6.6%
P / book
1.9
reciprocal yield 52.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
19.3
reciprocal yield 5.2%
Earnings yield
4.1%

Historical valuation

8 metrics
P / E historical average (3Y)
38.9×
reciprocal yield 2.6%
P / E historical average (5Y)
62.8×
reciprocal yield 1.6%
EV / revenue historical average (3Y)
18.1×
reciprocal yield 5.5%
EV / revenue historical average (5Y)
16.3×
reciprocal yield 6.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
4.1%
Trailing 12 months
Payout ratio
85.9%
Shareholder yield
3.5%
Dividend / share (TTM)
$1.51
Dividend growth YoY
+16.2%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-09-30

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-07

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
62.2%
Gross profit (TTM)
$192.35M
Operating profit (TTM)
—
Net income (TTM)
$355.40M
Trailing 12 months
Diluted EPS (TTM)
$1.61
FCF margin
—
Effective tax rate
2.4%

Per share

13 metrics
FFO per diluted share
—
AFFO per diluted share
—
Revenue per diluted share (TTM)
$2.55
Gross profit per diluted share (TTM)
$2.00
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$1.59
Operating cash flow per diluted share (TTM)
$2.00
Free cash flow per diluted share (TTM)
$1.32
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$18.12

Growth

11 metrics
Revenue growth YoY
+43.5%
Year over year
Net income growth YoY
+29.8%
Revenue (TTM)
$571.43M
Trailing 12 months
EPS growth YoY
+8.6%
Shares change YoY
+21.5%
Year over year · more shares
Revenue CAGR (3Y)
+34.4%
Revenue CAGR (5Y)
+21.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
+13.1%
FCF CAGR (3Y)
+24.3%
FCF CAGR (5Y)
+115.9%

Quality

14 metrics
Return on equity
7.9%
Return on assets
6.0%
Debt / equity
0.3
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$1.16B
Latest balance sheet
Cash & equivalents
$47.59M
Total assets
$5.93B
Total debt
$1.21B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$446.99M
Capital expenditures (TTM)
$2.94M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
519
13F filer change QoQ
+25
Institutional ownership
106.1%
Conviction holders (share of 13F filers)
1.2%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+5.1%
Holder tenure
13.3
Price vs estimated holder cost
+24.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
30.0%

Short interest

3 metrics
Short interest
4.6%
Latest settlement · 4.7 days to cover
Days to cover
4.7d
Short-squeeze score
60 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1590717 CUSIP 14174T107 13F (30d) 60 filings 60 filers Visit website Investor relations